Perhaps most well known for leading Draper Fisher Jurvetson’s (DFJ) early investment into Baidu—securing 25% of the then growing giant and two seats on the board—Dr. Finian Tan undeniably seems to be a man with foresight.

At the heart of it, he’s an investor with his senses tuned to the long-term game.

Now leading Vickers Venture, with a keen focus on medtech and deep tech, we ask Dr. Tan which part of his investment philosophy has served him well throughout time and what has evolved. Moreover, as the global internet business has matured exponentially, what created long-term value back in the early 2000s might not create long-term value now. We’ll be picking his brain to understand what he defines as long-term value and how that aids in discerning deal flow.

We Discuss:
-Successfully navigating the Chinese market as a Southeast Asia-based investor
-The impact of COVID-19 on medtech
-Where does the long-term value of technology lie beyond 2020?

————
Let's keep in touch:

•   / krasiaofficial  
•   / krasia  
•   / krasiaofficial  

KrAsia is connecting Asia's tech startup scene to the world.
Subscribe to our newsletter: https://kr-asia.com/subscribe